Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
Abstract Background PCDH10, one of the non-clustered protocadherins, is identified as a tumor suppressor gene in many tumors. Recently, promoter methylation of PCDH10 was found in diffuse large B-cell lymphoma (DLBCL) but not in normal lymph nodes, suggesting that its epigenetic aberrance is essenti...
Main Authors: | Wenting Huang, Xuemin Xue, Ling Shan, Tian Qiu, Lei Guo, Jianming Ying, Ning Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-12-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-017-3810-7 |
Similar Items
-
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma
by: Maria Cristina Curia, et al.
Published: (2019-05-01) -
Aberrant methylation of PCDH10 and RASSF1A genes in blood samples for non-invasive diagnosis and prognostic assessment of gastric cancer
by: Charinya Pimson, et al.
Published: (2016-06-01) -
Epigenetic Inactivation of Protocadherin 10 by Methylation in Colorectal Cancer
by: Sahar Tavakolian, et al.
Published: (2020-02-01) -
Epigenetic Silencing of the Protocadherin Family Member PCDH-γ-All in Astrocytomas
by: Anke Waha, et al.
Published: (2005-03-01) -
Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma
by: Ting-Xun Lu, et al.
Published: (2019-06-01)